[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK3106873T3 - Fremgangsmåde til detektering af cancer - Google Patents

Fremgangsmåde til detektering af cancer Download PDF

Info

Publication number
DK3106873T3
DK3106873T3 DK16181416.5T DK16181416T DK3106873T3 DK 3106873 T3 DK3106873 T3 DK 3106873T3 DK 16181416 T DK16181416 T DK 16181416T DK 3106873 T3 DK3106873 T3 DK 3106873T3
Authority
DK
Denmark
Prior art keywords
detecting cancer
cancer
detecting
Prior art date
Application number
DK16181416.5T
Other languages
English (en)
Inventor
Fumiyoshi Okano
Kana Suzuki
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Application granted granted Critical
Publication of DK3106873T3 publication Critical patent/DK3106873T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4727Calcium binding proteins, e.g. calmodulin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/723Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK16181416.5T 2007-10-25 2008-10-23 Fremgangsmåde til detektering af cancer DK3106873T3 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2007277747 2007-10-25
JP2007277697 2007-10-25
JP2007279512 2007-10-26
JP2007279580 2007-10-26
JP2008254170 2008-09-30
EP08842391.8A EP2207037B1 (en) 2007-10-25 2008-10-23 Method for detection of cancer

Publications (1)

Publication Number Publication Date
DK3106873T3 true DK3106873T3 (da) 2019-09-23

Family

ID=40579577

Family Applications (4)

Application Number Title Priority Date Filing Date
DK16181433.0T DK3106875T3 (da) 2007-10-25 2008-10-23 Fremgangsmåde til detektering af cancer
DK08842391.8T DK2207037T3 (da) 2007-10-25 2008-10-23 Fremgangsmåde til detektering af cancer
DK16181416.5T DK3106873T3 (da) 2007-10-25 2008-10-23 Fremgangsmåde til detektering af cancer
DK16181429.8T DK3106874T3 (da) 2007-10-25 2008-10-23 Fremgangsmåde til detektering af cancer

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DK16181433.0T DK3106875T3 (da) 2007-10-25 2008-10-23 Fremgangsmåde til detektering af cancer
DK08842391.8T DK2207037T3 (da) 2007-10-25 2008-10-23 Fremgangsmåde til detektering af cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK16181429.8T DK3106874T3 (da) 2007-10-25 2008-10-23 Fremgangsmåde til detektering af cancer

Country Status (11)

Country Link
US (1) US9249409B2 (da)
EP (4) EP2207037B1 (da)
JP (4) JP5439815B2 (da)
KR (4) KR101715666B1 (da)
CN (5) CN106086177B (da)
AU (1) AU2008314929B2 (da)
CA (4) CA2703356C (da)
DK (4) DK3106875T3 (da)
ES (4) ES2798266T3 (da)
PT (4) PT3106873T (da)
WO (1) WO2009054475A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009278387B2 (en) 2008-08-05 2015-07-09 Toray Industries, Inc. Cancer detection method
JP5691172B2 (ja) 2008-08-05 2015-04-01 東レ株式会社 癌の治療及び予防用医薬組成物
MX340015B (es) 2010-02-04 2016-06-22 Toray Industries Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
RU2445625C1 (ru) * 2011-01-11 2012-03-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Способ прогнозирования риска развития многоузловых поражений при лейомиоме матки
PT2741085T (pt) 2011-08-04 2017-06-30 Toray Industries Método para a deteção de cancro prancreático
DK2740796T3 (da) 2011-08-04 2017-07-24 Toray Industries Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer
CN103717238B (zh) 2011-08-04 2016-10-12 东丽株式会社 胰癌的治疗和/或预防用药物组合物
BR112014021102A2 (pt) 2012-02-21 2021-12-28 Toray Industries Anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo
BR112014021101A2 (pt) 2012-02-21 2022-03-22 Toray Industries Anticorpo, composição farmacêutica, droga de combinação, dna e método de tratamento e/ou prevenção de câncer, uso de um anticorpo
RU2640245C2 (ru) 2012-03-30 2017-12-27 Торэй Индастриз, Инк. Фармацевтическая композиция для лечения и/или предотвращения рака печени
PT2832366T (pt) 2012-03-30 2018-01-25 Toray Industries Composição farmacêutica para o tratamento e/ou a prevenção de cancro de vesícula biliar
CN104471403B (zh) * 2012-07-19 2017-03-01 东丽株式会社 癌的检测方法
PT2876447T (pt) 2012-07-19 2020-02-03 Toray Industries Método para deteção de cancro
KR102255616B1 (ko) 2013-08-09 2021-05-25 도레이 카부시키가이샤 암의 치료 및/또는 예방용 의약 조성물
JP5995117B2 (ja) * 2015-01-26 2016-09-21 国立大学法人 筑波大学 可溶型cd155タンパク質を用いた癌の検出方法
US11959928B2 (en) * 2017-12-20 2024-04-16 Trears Ltd. Method for measuring average cortisol and glucose concentrations in earwax

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355623B2 (en) * 1998-09-24 2002-03-12 Hopital-Sainte-Justine Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage
JP2005506033A (ja) * 2000-10-13 2005-03-03 イーオーエス バイオテクノロジー インコーポレイテッド 前立腺癌の診断法、前立腺癌モジュレータースクリーニングの組成物及び方法
US20040029114A1 (en) * 2001-01-24 2004-02-12 Eos Technology, Inc. Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
CA2447212A1 (en) * 2001-03-29 2002-10-24 Incyte Genomics, Inc. Secretory molecules
US20030108963A1 (en) * 2001-07-25 2003-06-12 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer
US20030124579A1 (en) * 2001-09-05 2003-07-03 Eos Biotechnology, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
US20070237770A1 (en) * 2001-11-30 2007-10-11 Albert Lai Novel compositions and methods in cancer
AU2003272423A1 (en) * 2002-09-13 2004-04-30 University Of Massachusetts Centrosome proteins and uses thereof
JP2006517094A (ja) * 2002-10-22 2006-07-20 ヌベロ, インコーポレイテッド 新規核酸およびポリペプチド
CN1852974A (zh) * 2003-06-09 2006-10-25 密歇根大学董事会 用于治疗和诊断癌症的组合物和方法
US10179935B2 (en) * 2003-07-17 2019-01-15 Pacific Edge Limited Markers for detection of gastric cancer
US7807392B1 (en) * 2003-09-15 2010-10-05 Celera Corporation Lung disease targets and uses thereof
EP1522594A3 (en) * 2003-10-06 2005-06-22 Bayer HealthCare AG Methods and kits for investigating cancer
CN1657537A (zh) * 2004-02-19 2005-08-24 中国人民解放军军事医学科学院放射医学研究所 一种中心体定位的新基因及其在医药领域中的应用
JP2007522791A (ja) * 2004-02-24 2007-08-16 オンコセラピー・サイエンス株式会社 結腸直腸癌を診断する方法
US7560233B2 (en) * 2004-06-16 2009-07-14 University Of Massachusetts Oxidative DNA damage protection
US20070099209A1 (en) * 2005-06-13 2007-05-03 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
ES2824684T3 (es) * 2007-10-25 2021-05-13 Toray Industries Inductor de la respuesta inmunitaria

Also Published As

Publication number Publication date
EP2207037A1 (en) 2010-07-14
DK3106875T3 (da) 2020-06-02
EP3106874A1 (en) 2016-12-21
JP5713035B2 (ja) 2015-05-07
JP2013101147A (ja) 2013-05-23
EP3106875A1 (en) 2016-12-21
JP2013101148A (ja) 2013-05-23
CA3076730C (en) 2022-06-21
DK2207037T3 (da) 2016-12-19
JP5713037B2 (ja) 2015-05-07
CN106053833B (zh) 2018-12-25
CA3076717A1 (en) 2009-04-30
EP3106874B1 (en) 2020-04-01
CN106086177B (zh) 2021-09-10
JPWO2009054475A1 (ja) 2011-03-10
KR101633351B1 (ko) 2016-06-27
KR101715666B1 (ko) 2017-03-13
CN106093398A (zh) 2016-11-09
ES2788152T3 (es) 2020-10-20
CA3076730A1 (en) 2009-04-30
KR20100083768A (ko) 2010-07-22
PT3106874T (pt) 2020-05-08
KR20150041807A (ko) 2015-04-17
EP3106873A1 (en) 2016-12-21
KR101715661B1 (ko) 2017-03-13
KR20150041809A (ko) 2015-04-17
US20100297646A1 (en) 2010-11-25
EP3106873B1 (en) 2019-07-17
AU2008314929A1 (en) 2009-04-30
ES2605646T3 (es) 2017-03-15
CN106086177A (zh) 2016-11-09
JP5713036B2 (ja) 2015-05-07
KR20150041808A (ko) 2015-04-17
EP2207037A4 (en) 2011-03-16
CN101836116A (zh) 2010-09-15
JP5439815B2 (ja) 2014-03-12
ES2798266T3 (es) 2020-12-10
US9249409B2 (en) 2016-02-02
CA2703356A1 (en) 2009-04-30
ES2748390T3 (es) 2020-03-16
WO2009054475A1 (ja) 2009-04-30
CN106053833A (zh) 2016-10-26
PT3106873T (pt) 2019-10-18
CA3076845C (en) 2022-06-07
PT3106875T (pt) 2020-06-22
JP2013101149A (ja) 2013-05-23
AU2008314929B2 (en) 2014-07-10
CN106093399A (zh) 2016-11-09
EP3106875B1 (en) 2020-04-29
CN106093399B (zh) 2019-01-25
CA3076845A1 (en) 2009-04-30
CA2703356C (en) 2020-05-05
CA3076717C (en) 2023-01-03
PT2207037T (pt) 2016-12-09
CN106093398B (zh) 2019-01-29
EP2207037B1 (en) 2016-09-07
DK3106874T3 (da) 2020-06-02

Similar Documents

Publication Publication Date Title
DK2325648T3 (da) Fremgangsmåde til detektering af cancer
DK3106873T3 (da) Fremgangsmåde til detektering af cancer
DK2504451T3 (da) Fremgangsmåder til at forudsige det kliniske forløb af cancer
DK3730045T3 (da) Fremgangsmåde til indføring af en analytsensor
DK2126801T3 (da) Fremgangsmåde til udvælgelse af information
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0817726A2 (pt) Método
DK3329775T3 (da) Fremgangsmåder til syntese af diarylthiohydantoin- og diarylhydantoinforbindelser
DK2068927T3 (da) Fremgangsmåder til reducering af eosinofilniveauer
DK3289876T3 (da) Forbindelser til behandling af cancer
DK2183753T3 (da) Fremgangsmåder til køling
BRPI0812176A2 (pt) Método de cimentar poço
BRPI0919116A2 (pt) método
DK2293816T3 (da) Fremgangsmåder til behandling af reumatoid arthritis
NO20085322L (no) Fremgangsmate for raskere ansiktsdeteksjon
DK2215031T3 (da) Fremgangsmåde til bearbejdning af pozzolaner
DK2111555T3 (da) Diagnosticering af præeklampsi
DK2313489T3 (da) Fremstillingsmetode
DK2313364T3 (da) Fremgangsmåder til detektering af symmetrisk demethylarginin
DK3214083T3 (da) Fremgangsmåde til fremstilling af quinolonforbindelser
DK2361388T3 (da) Fremgangsmåder til karakterisering af molekyler
BRPI0813681A2 (pt) Detecção de coproantígeno de nematelminto
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
DK3085794T3 (da) Fremgangsmåde til detektion af et oligonukleotid